Neuroscientific Biopharmaceuticals Ltd ACN 102 832 995
Climate Impact & Sustainability Data (2022)
Reporting Period: 2022
Environmental Metrics
ESG Focus Areas
- Environmental
- Social
- Governance
Governance Achievements
- Established anti-bribery and anti-corruption policy
- Established whistleblower protection policy
- Established diversity policy
Climate Goals & Targets
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: ASX Corporate Governance Principles and Recommendations – 4th Edition